Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (OneStep-1)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dipexium Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01590758
First received: April 27, 2012
Last updated: August 8, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2016
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)